Thailand’s tourism numbers for 2025 are proof that the industry is not immune to shocks. Thailand can recover. But recovery will come from steady fixes, not slogans. Thailand’s long-running tourism ...

The 'Lost' and 'Ant Man' star revealed in a health update the “bad news about my concussion” including “decreased brain capacity” after a May 2025 holiday mishap in Hawaii. By Etan Vlessing Canada ...

Novo Nordisk A/S is rated a buy, driven by FDA approval of its oral Wegovy, strong fundamentals, and attractive valuation versus Eli Lilly. Recent clinical data and first-mover advantage position ...

Evangeline Lilly is sharing an update on her health following an unfortunate accident in May 2025. In an Instagram video posted on Friday, Jan. 2, the 46-year-old "Lost" star shared that she has ...

Southern Hospitality‘s Grace Lilly has been arrested for harassment — with police allegedly finding “happy pills” in her purse. Us Weekly can confirm that Lilly, 27, was booked in Charleston, South ...

Its lineup and pipeline put it well ahead of even its closest competitor. The drugmaker should continue riding this wave for the foreseeable future. Furthermore, Novo Nordisk is anticipating ...

Add Yahoo as a preferred source to see more of our stories on Google. The 26-year-old pro-golfer shared an intimate shot of her cuddling with Albon, 29, while wearing baseball caps. Muni He kept it ...

Lily Muni He shared a slice of vacation life on Monday, December 22, when she posted photos to Instagram from her trip to Thailand alongside boyfriend, Formula 1 driver Alex Albon. The 26-year-old pro ...

Eli Lilly is leading the market for GLP-1 medications (for weight loss and diabetes). The company overtook early GLP-1 leader Novo Nordisk. Eli Lilly is increasingly reliant on its GLP-1 drugs. Eli ...

Eli Lilly just agreed to lower the price of its blockbuster GLP-1 weight loss drug. More than half of the company's revenue comes from just two weight loss drugs. Wall Street may be pricing in too ...

Eli Lilly stock reached a new 52-week high on Nov. 10, up 4.7% and extending a month-long rally of 16%, after the pharmaceutical giant announced two strategic deals, following the highly anticipated ...